MedPath

S&B Heat Stress Pilot Protocols

Not Applicable
Completed
Conditions
Thermal Discomfort
Interventions
Device: Group A
Device: Group B
Registration Number
NCT06094764
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

The purpose of this study is to develop a heat stress program for the construction industry and evaluate its feasibility and appeal.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • employed at S&B
  • work more than 20 hours a week
Exclusion Criteria
  • severe chronic disease (e.g. severe pulmonary or cardiovascular disease
  • history of severe heat stroke
  • use of a pacemaker
  • any medical issue which would render the participant unable to wear a chest monitor and cooling vest.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Personal monitoring device and a cooling vest , Then personal monitoring device onlyGroup A-
Personal monitoring device only, Then personal monitoring device and a cooling vestGroup B-
Primary Outcome Measures
NameTimeMethod
Thermal discomfort as assessed by the thermal comfort scaleend of study (about 2 hours after start)

The thermal comfort scale is a 7-point scale that asks participants to rate their level of thermal comfort ranging from the sensation of "cold, cool, slightly cool, neutral, slightly warm, warm, hot

Secondary Outcome Measures
NameTimeMethod
Respiratory rate as assessed by the Zephyr BioHarness 3.0 devicefrom baseline to end of study (2 hours after baseline)
Change in Heart rate as assessed by the Zephyr BioHarness 3.0 devicefrom baseline to end of study (2 hours after baseline)
Estimated core body temperature as assessed by the Zephyr BioHarness 3.0 devicefrom baseline to end of study (2 hours after baseline)
Caloric burn as assessed by the Zephyr BioHarness 3.0 devicefrom baseline to end of study (2 hours after baseline)
Hydration status as indicated by urine specific gravity as assessed by a clinical refractometer analysis of urine samplefrom baseline to end of study (2 hours after baseline)

Trial Locations

Locations (1)

The University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath